7BIO

CAS No. 916440-85-2

7BIO( —— )

Catalog No. M27496 CAS No. 916440-85-2

7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
5MG 36 In Stock
10MG 55 In Stock
25MG 112 In Stock
50MG 175 In Stock
100MG 277 In Stock
200MG 393 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7BIO
  • Note
    Research use only, not for human use.
  • Brief Description
    7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.
  • Description
    7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.
  • In Vitro
    7BIO (1 and 10 μM; 24 hours) has neuroprotective effects and can prevent, but cannot rescue Aβ1?42 oligomer-induced cell death in SH-SY5Y cells. Cell Viability AssayCell Line:SH-SY5Y cellsConcentration:1 and 10 μMIncubation Time:24 hoursResult:Inhibit Aβ oligomer-induced neuronal death. 7BIO prevented, but did not rescue Aβ1?42 oligomer-induced cell death in SH-SY5Y cells.
  • In Vivo
    7Bio (2.3, 7.0, and 23.3 μg/kg; bilateral ventricle injection) significantly attenuates Aβ oligomer-induced impairment of recognition, spatial learning and memory in mice.7Bio (2.3, 7.0, and 23.3 μg/kg; bilateral ventricle injection) decreases Aβ oligomer-induced increase of TNF-α and IL-6 production in the brain and the expression of synapsin-1 and PSD-95 in the hippocampal region of mice.7Bio (2.3, 7.0, and 23.3 μg/kg; bilateral ventricle injection) attenuates Aβ oligomer-induced increase expression of pTau, activation of microglia and astrogliosis in the brain of mice.7Bio (2.3, 7.0, and 23.3 μg/kg; bilateral ventricle injection) prevents decreased expression of pSer9-GSK3β and has no significant effects on the Tau protein level. Animal Model:8 weeks mice (30 g)Dosage:2.3, 7.0, and 23.3 μg/kg Administration:bilateral ventricle injection Result:Attenuates Aβ oligomer-induced impairment of recognition, spatial learning and memory in mice.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    FLT
  • Recptor
    glutamine synthetase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    916440-85-2
  • Formula Weight
    356.179
  • Molecular Formula
    C16H10BrN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (701.91 mM)
  • SMILES
    O\N=C1\C(\Nc2ccccc\12)=C1\C(=O)Nc2c1cccc2Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Premakumar R, Sorger GJ, Gooden D. Repression of nitrate reductase in Neurospora studied by using L-methionine-DL-sulfoximine and glutamine auxotroph gln-1b. J Bacteriol. 1980;143(1):411-415.
molnova catalog
related products
  • Gilteritinib hemifum...

    Gilteritinib hemifumarate (ASP2215 hemifumarate) is a potent ATP-competitive dual FLT3 (IC50: 0.29 nM) and AXL (IC50: 0.73 nM) inhibitor for the treatment of relapsed or refractory FLT3 mutant AML.

  • PRT062607 hydrochlor...

    PRT062607 (P505-15, BIIB057) hydrochloride is a novel, highly selective Syk inhibitor with IC50 of 1 nM in cell-free assays.

  • TG-89

    TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer.